Webinar with Dr. Eric McDade on May 4, 2024, on the Primary Prevention Trial.
Category: Webinars
Webinar: Amyloid Removal Trial (ART) (Links to an external site)
Webinar with Dr. Randall Bateman on May 4, 2024, on the Amyloid Removal Trial (ART) for former participants in the open-label extension trial with gantenerumab.
Webinar: Amyloid Removal Trial Q&A (Links to an external site)
Question and answer session with Dr. Randall Bateman on December 16, 2023, on the Amyloid Removal Trial (ART) for former participants in the open-label extension trial with gantenerumab.
Webinar: Open-label extension trial with gantenerumab Q&A (Links to an external site)
Question and answer session with Dr. Randall Bateman on August 14, 2023, on the ending of the open-label extension trial with gantenerumab.
Audio Presentation: Open-label extension trial with gantenerumab (Links to an external site)
Audio presentation with Dr. Randall Bateman on April 29, 2023, on the open-label extension trial with gantenerumab.
Webinar: The Primary Prevention Clinical trial Q&A (Links to an external site)
Question and answer session with Dr. Eric McDade on December 21, 2022, on the Primary Prevention Clinical trial.
Slides & Audio Presentation: Gantenerumab (Links to an external site)
Slides and audio presentation from November 19, 2022, on gantenerumab. This recording is password protected.
Webinar: Lecanemab Q&A (Links to an external site)
Question and answer session with Dr. Randall Bateman and Dr. Eric McDade on September 30, 2022, on lecanemab.
Slides & Audio Presentation (Links to an external site)
Slides and audio presentation from May 14, 2022.
Slides & Audio Presentation
View Slide presentation from Nov 2021. In response, a memo from Dr. Bateman and Dr. McDade seeks to clarify reasons for new eligibility criteria for the Tau NexGen clinical trial.